N5-0003 — Annual report 2010
1.
Patent application of TLR signaling inhibitors based on TIR domain fusion

We discovered that dimerization of TIR domain fusion significantly improves the inhibition of TLR signaling. We prapared a fusion between TIR domain of MyD88 adapter with the N-terminal domain of the bacterial TcpB and with artificial dimerization domain GCN, which additionally improved inhibition.

COBISS.SI-ID: 4619290